Hepatitis vaccines containing 3-O-deacylated monophoshoryl...

Details Hepatitis vaccines containing 3-O-deacylated monophoshoryl... Hepatitis vaccines containing 3-O-deacylated monophoshoryl...

2005-05-17

2005-05-17

Housel, James (Department: 1648)

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

Lipid or oil

C424S184100, C424S189100, C424S204100, C424S201100, C424S225100, C424S226100, C424S227100, C424S278100

Reexamination Certificate

active

06893644

ABSTRACT:
A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid. A combination vaccines including the vaccine formulation are also described.

REFERENCES:
patent: 4857634 (1989-08-01), Minor et al.
patent: 4912094 (1990-03-01), Myers et al.
patent: 5776468 (1998-07-01), Hauser et al.
patent: 5972346 (1999-10-01), Hauser et al.
patent: 6372227 (2002-04-01), Garcon et al.
patent: 6488934 (2002-12-01), Hauser et al.
patent: 6620414 (2003-09-01), Garcon-Johnson et al.
patent: 0 175 261 (1986-03-01), None
patent: 0 318 216 (1989-05-01), None
patent: 0 414 374 (1991-02-01), None
patent: 0 419 182 (1991-03-01), None
patent: 2 220 211 (1989-06-01), None
patent: 2212511 (1989-07-01), None
patent: WO 8912462 (1989-12-01), None
patent: WO 9116926 (1991-11-01), None
patent: WO 9206113 (1992-04-01), None
patent: WO 9211291 (1992-07-01), None
patent: WO 9216231 (1992-10-01), None
patent: WO 9816556 (1992-10-01), None
patent: WO 9310152 (1993-05-01), None
MAnnucci et al. Arch Intern Med 1989 vol. 149, pp. 1333-1337.*
Wagner et al. Clinical Investigation 1992 vol. 70, pp. 585-587.*
Coursaget, et a., “Simultaneous Administration of Diptheria-Tetanus-Pertussis-Pollo and Hepatitis B Vaccines in a Simplified Immunization Program: Immune Response to Diphtheria Toxoid, Tetanus Toxoid, Pertussis, and Hepatitis B Surface Antigen”,Infection and Immunity, 51: No. 3, pp. 784-787 (1986).
Myers, et al., “ A Critical Determinant of Lipid A Endotoxic Activity”,Cellular&Molecular Aspects of Endotoxin Reactions, pp. 145-156 (1990).
Jilg, et al., “Hepatitis A Vaccine”,Vaccines, 2nd edition, pp. 583-595 (1994).
Johnson, et al., “Advances in Experimental Medicine and Biology”, vol. 256 pp. 567-579 (1990).
Takayama, et al., “Adjuvant Activity of Non-Ionic Block Copolymers. V. Modulation of Antibody Isotype by Lipopolysaccharides, Lipid A and Precursors,”Vaccine 9: 257-262 (1989).
Brynestad, et al., “Influence of Peptide Acylation, Liposome Incorporation, and Synthetic Immunomodulators on the Immunogenicity of a 1-23 Peptide of Glycoprotein D of Herpes Simplex Virus: Implications for Subunit Vaccines,”J. Virol. 64pp. 680-685 (1990).
Tsujimoto, et al., “Enhancement of Humoral Immune Responses Against Viral Vaccines by a Non-pyrogenic 6-0 Acyl-Muramyldipeptide ad synthetic low toxicity analogues of lipid A,”Vaccine, 7: 39-48 (1989).
Richards, et al., “Immunogenicity of Liposomal Malaria Sporozoite Antigen in Monkeys: Adjuvant Effects of Aluminum Hydroxide and Non-Pyrogenic Liposomal Lipid A,”Vaccine, 7, pp: 506-512 (1989).
Farci, et al., “Lack of Protective Immunity Against Reinfection with hepatitis C Virus,”Science, 258: pp. 135-140 (1992).
Koff, RS, “A Redoubtable Obstacle to a Hepatitis C Vaccine,”Gastroenterology, 104: pp. 1228-1229 (1993).

Affiliated with

Also associated with

Rating

Hepatitis vaccines containing 3-O-deacylated monophoshoryl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis vaccines containing 3-O-deacylated monophoshoryl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis vaccines containing 3-O-deacylated monophoshoryl... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3380266